Sciencast Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,872
Closed -$208K 294
2025
Q1
$208K Buy
+2,872
New +$206K 0.05% 221
2024
Q3
Sell
-25,483
Closed -$2.35M 277
2024
Q2
$2.35M Buy
+25,483
New +$2.26M 0.82% 45
2023
Q4
Sell
-15,009
Closed -$1.04M 285
2023
Q3
$1.04M Buy
+15,009
New +$1.21M 0.47% 67
2022
Q2
Sell
-27,022
Closed -$3.19M 465
2022
Q1
$3.19M Buy
+27,022
New +$3.03M 0.73% 32
2021
Q1
Sell
-9,932
Closed -$869K 546
2020
Q4
$869K Buy
+9,932
New +$824K 0.18% 177
2020
Q2
Sell
-26,100
Closed -$1.64M 438
2020
Q1
$1.64M Buy
+26,100
New +$1.88M 0.46% 12
2019
Q3
Sell
-25,800
Closed -$1.67M 391
2019
Q2
$1.67M Buy
+25,800
New +$1.56M 0.94% 7
2017
Q4
Sell
-33,258
Closed -$1.14M 345
2017
Q3
$1.14M Buy
33,258
+22,941
+222% +$875K 0.63% 44
2017
Q2
$407K Sell
10,317
-1,350
-12% -$49.3K 0.23% 166
2017
Q1
$366 Buy
+11,667
New +$365K 0.2% 176
2016
Q3
Sell
-12,900
Closed -$429K 156
2016
Q2
$429K Sell
12,900
-1,200
-9% -$41.1K 0.19% 173
2016
Q1
$415K Sell
14,100
-1,920
-12% -$53K 0.33% 103
2015
Q4
$422K Buy
+16,020
New +$416K 0.44% 83

Other funds holding EW

Sciencast Management's EW Position: Q2 2025 in Review

Sciencast Management sold out of Edwards Lifesciences (EW) in Q2 2025, closing a stake of 2,872 shares — an estimated $208K sold.

Sciencast Management first reported a position in EW in Q4 2015 and held it in 13 quarters. The position peaked at $3.19M in Q1 2022. 1,259 funds tracked by Wall St. Rank hold EW as of Q2 2025.

  • Sciencast Management reported no remaining Edwards Lifesciences position as of Q2 2025 after selling out during the quarter.
  • Sciencast Management sold 2,872 Edwards Lifesciences shares in Q2 2025, an estimated $208K.
  • Sciencast Management first reported a position in Edwards Lifesciences in Q4 2015 and held it in 13 quarters.
  • Sciencast Management's Edwards Lifesciences position peaked at $3.19M in Q1 2022.
  • 1,259 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2025.

Based on Sciencast Management's 13F filing for Q2 2025, filed 14 Aug 2025.